Top 10 Pharmaceutical Company to Deploy Full Suite of iContracts Solutions
Raritan, NJ – January 15, 2014 – iContracts, a leading provider of solutions for managing corporate contracts, commitments, and compliance today announced Aurobindo USA has selected iContracts full suite of solutions to manage commercial contracts, Accrual and Gross to Net Processes and help ensure compliance with Government pricing programs including Medicaid, state programs and associated calculations and reporting. iContracts solutions help life sciences companies optimize performance by streamlining and improving their contracting processes.
Recognized as the fastest growing pharmaceutical company in 2012, Aurobindo USA has a diverse product portfolio with more than 125 product families and 450 individual product packages, representing a wide range of therapeutic categories. Their commitment to delivering a broad portfolio of quality, affordable generic pharmaceuticals to pharmacists and patients has made them a top 10 pharmaceutical company in terms of total prescriptions dispensed.
Robert Cunard, Aurobindo USA’s CEO noted,“We are very confident in our decision to utilize the iContracts suite of solutions. We look forward to implementing the software to enhance our customer experience and provide additional efficiency to Aurobindo USA.”
Aurobindo will utilize iContracts Chargeback Payer, Rebate Payer, Medicaid Payer, Government Pricing, Accrual Manager and Analytics & Reporting. These solutions are proven to strengthen compliance and revenue management processes.
“We are pleased to welcome Aurobindo USA to the iContracts family,” noted Leigh Powell, Chief Executive Officer of iContracts. “We are profoundly honored to serve one of the largest prescription drug producers in the world with our highly scalable cloud based Better Contracting Solutions platform. Aurobindo’s commitment to providing affordable, high quality pharmaceutical products around the world has improved countless lives and formed the very foundation of their dramatic growth. We look forward to a strong relationship for years to come with Aurobindo.”
iContracts’ solutions are available as an “on demand” service or as a behind-the-firewall offering and are built on iContracts’ revolutionary BCS platform featuring an advanced data architecture, rich functionality and Simplified Common User Interface (SCUI) enabling users to execute any process after learning just two basic page formats. This groundbreaking design drastically reduces implementation; training and future upgrade timeframes and costs.
About iContracts
iContracts’ goal is simple – to deliver better solutions for managing contracts that are faster, easier and less expensive to implement. This mantra is reflected in everything we do. Our software is generations ahead of other solutions, powered by a Simplified Common User Interface (SCUI) that makes every user an “expert” by learning just two simple, reusable views and backed by the most highly evolved data architecture in the industry – built by technologists with considerable and unique experience in building contract management solutions for the Life Sciences industry. This deep understanding and straightforward approach shows in everything we do. iContracts comprehensive suite of solutions manages all aspects of a Life Science company’s chargeback, rebate and Medicaid processes as well as other incentive agreements and Government Pricing compliance at all levels. Our solutions are enterprise-class and can be quickly and easily integrated with any off-the-shelf or custom system to meet exacting business requirements without the army of consultants and endless fees associated with other products and providers. For more information, please visit www.icontracts.com.
About Aurobindo USA
As one of the largest suppliers of API across the globe, combined with quality, manufacturing, and formulation expertise, Aurobindo has created a vertically integrated process poised to continue expansion within the US market. In addition to our global production, Aurobindo operates 2 facilities in central New Jersey, with approximately 300,000 square feet of laboratory, manufacturing, distribution, and administrative space with more than 200 talented associates. Through our flexibility in balancing highly efficient global production with in-market capabilities for packaging and controlled substance development and manufacture, Aurobindo is diversifying into a wide range of products and dosage forms. With a consistent focus on quality, affordability, and customer satisfaction, Aurobindo is well positioned to deliver consistent growth and value to our customer partners in the years ahead. For more information, please visit www.aurobindousa.com.